DS

Dalip Singh

Active Director Director DIN 09524501
DIN 09524501 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Dalip Singh

Data last updated:

Dalip Singh is a Director at Crius Life Sciences Private Limited (since 2022). The company operates in Healthcare. Crius Life Sciences Private Limited reported revenue of ₹117 Cr (FY 2025).

DIN 09524501
Primary Designation Director
Industry Healthcare
First Appointment 04 Mar 2022
Oldest Company Age 10 yrs
Largest company Crius Life Sciences Private Limited · ₹117 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crius Life Sciences Private Limited U24232HP2016PTC001137
Director04 Mar 20222016₹117 Cr (FY 2025)Active

Board colleagues of Dalip Singh

Directorship timeline

Open interactive timeline →
Crius Life Sciences Private Limited
Premium access

Shareholding and investment profile for Dalip Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dalip Singh

Dalip Singh currently holds 1 directorship: Crius Life Sciences Private Limited (Director, since 04 Mar 2022, revenue ₹117 Cr (FY 2025)).

Dalip Singh was first appointed on 04 Mar 2022 as Director at Crius Life Sciences Private Limited.

The current boards of Dalip Singh's companies include Birendra Chalaune (Crius Life Sciences Private Limited), Chinni Venkata Subbarao (Crius Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available